Search
Close this search box.

The Importance of Protecting Your Skin this Fall

As summer comes to an end, the weather gets cooler and the days grow shorter, leaving many people to store their sunscreen for the upcoming season. However, even in the fall months, ultraviolet (UV) protection is important in protecting your skin. In fact, UVA rays—which make up 95% of all UV rays—are almost as equally […]

2018 Aesthetic Awards: Non-Physician Non-Surgical Innovator of the Year Award

Over the past several years, Mr. Sardano, CEO of Sensus Healthcare, has worked tirelessly to offer a non-surgical solution for non-melanoma skin cancer and an effective treatment for keloid scars. The state-of-the-art Superficial Radio Therapy (SRT) technology is the non-surgical treatment option dermatologists and oncologists have been waiting for. Upon receiving the “Non-Physician Non-Surgical Innovator of […]

Sensus Healthcare, Inc. Announces Underwriters’ Exercise of Option

BOCA RATON, Fla., Sept. 21, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it has issued an additional 330,882 shares of its common stock pursuant to the exercise in full of the underwriters’ option received in connection with Sensus’ recently completed public offering of its common stock. After giving effect to the full […]

Sensus Healthcare, Inc. Announces Closing of Public Offering of Common Stock

BOCA RATON, Fla., Sept. 17, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it completed a public offering of 2,205,882 shares of its common stock, par value $0.01 per share, at a public offering price of $6.80 per share. All of the shares were offered by Sensus. The shares are listed on The […]

Sensus Healthcare, Inc. Announces Pricing of Public Offering of Common Stock

BOCA RATON, Fla., Sept. 13, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it has priced an underwritten public offering of 2,205,882 shares of its common stock, par value $0.01 per share, at a public offering price of $6.80 per share. Sensus has granted a 30-day option to purchase up to an additional […]

Sensus Healthcare, Inc. Announces Commencement of Public Offering of Common Stock

BOCA RATON, Fla., Sept. 12, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it commenced a public offering of its common stock, par value $0.01 per share. B. Riley FBR is serving as the lead underwriter and sole book-running manager for the offering. Sensus intends to use the net proceeds from the offering […]

Sensus Healthcare Presents at National Cancer Care Alliance Leadership Board and Practice Quarterly Meeting

BOCA RATON, Fla., Sept. 7, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, President and Chief Executive Officer, participated at the National Cancer Care Alliance (NCCA) Leadership Board and Practice Quarterly […]